June 21, 2022

Kester v. Janssen Pharmaceuticals

Track this case

Case Number:

22-7026

Court:

Appellate - 10th Circuit

Nature of Suit:

4367 Health Care / Pharma

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 21, 2023

    10th Circ. Won't Revive Suit Over Janssen's Levaquin

    A woman whose side effects from antibiotic Levaquin persisted after she stopped taking the drug can't restart her suit against Janssen Pharmaceuticals Inc., an Oklahoma appellate panel has found, ruling that she sued outside Oklahoma's two-year statute of limitations on negligence and product liability claims.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS